Thu, Apr 17, 2014, 7:12 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Halozyme Therapeutics, Inc. Message Board

  • howeeme howeeme Jul 18, 2013 9:48 AM Flag

    whogo70 and Fezz

    While I love your entusiasm News like this is nothing special either way. FDA approval is at least a year off in the distance and nobody cares. Like I have said in the past Partnerships, Revenues, Approvals and Positive Later Stage trial news will make this stock go higher. All of your excitement and speculation may make you feel better but it ain't gonna move the stock.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • If your time horizon is next week then I can understand why you don't see anything special.

    • Yeah, it does no matter . I guess that is why HyQ was talked about over a dozen times on the Baxter call, analyst had follow up questions and a factory is being built in Georgia to help support HyQ sales. This is not speculation. Rome was not built in a day.

      Sentiment: Strong Buy

      • 1 Reply to hopefully_right
      • The factory was being built in Georgia to support Gammagard Sales to Alzeimers patients. That doesn't seem to be moving along very fast now, does it. Baxter is very excited about HYQ, thats obvious. I'm saying that right now this news means nothing for the stock. See my posts regarding what the drivers of the price will be. Also, look at the price today. It is a non-event. BTW, I own a very large position in this stock for over 6 years now and will not sell until Kirk decides its time. But, I think all of this speculation and bringing up old news is a waste of time. Bring the board something that we don't know and I will show some respect.

 
HALO
7.57+0.02(+0.26%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.